Protocol to evaluate quality of life in patients with peripheral arterial disease in the UK who have been prescribed cilostazol (Pletal) as part of their clinical management plan

Trial Profile

Protocol to evaluate quality of life in patients with peripheral arterial disease in the UK who have been prescribed cilostazol (Pletal) as part of their clinical management plan

Active, no longer recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 01 Jun 2006

At a glance

  • Drugs Cilostazol (Primary)
  • Indications Embolism and thrombosis; Peripheral arterial disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Jun 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top